These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17850056)

  • 1. Discovery of a new series of potent and selective linear tachykinin NK2 receptor antagonists.
    Fedi V; Altamura M; Catalioto RM; Giannotti D; Giolitti A; Giuliani S; Guidi A; Harmat NJ; Lecci A; Meini S; Nannicini R; Pasqui F; Tramontana M; Triolo A; Maggi CA
    J Med Chem; 2007 Oct; 50(20):4793-807. PubMed ID: 17850056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha,alpha-Cyclopentaneglycine dipeptides capped with biaryls as tachykinin NK(2) receptor antagonists.
    Porcelloni M; D'Andrea P; Rossi C; Sisto A; Ettorre A; Madami A; Altamura M; Giuliani S; Meini S; Fattori D
    ChemMedChem; 2008 Jul; 3(7):1048-60. PubMed ID: 18399514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation on C- and N-terminal moieties of a series of potent and selective linear tachykinin NK(2) receptor antagonists.
    Gensini M; Altamura M; Dimoulas T; Fedi V; Giannotti D; Giuliani S; Guidi A; Harmat NJ; Meini S; Nannicini R; Pasqui F; Tramontana M; Triolo A; Maggi CA
    ChemMedChem; 2010 Jan; 5(1):65-78. PubMed ID: 19957262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of 6-methyl-benzo[b]thiophene-2-carboxylic acid (1-[(S)-1-benzyl-4-[4-(tetrahydropyran-4-ylmethyl)piperazin-1-yl]butylcarbamoyl]cyclopentyl)amide, potent antagonist of the neurokinin-2 receptor.
    Fattori D; Porcelloni M; D'Andrea P; Catalioto RM; Ettorre A; Giuliani S; Marastoni E; Mauro S; Meini S; Rossi C; Altamura M; Maggi CA
    J Med Chem; 2010 May; 53(10):4148-65. PubMed ID: 20408549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.
    Giuliani S; Patacchini R; Barbanti G; Turini D; Rovero P; Quartara L; Giachetti A; Maggi CA
    J Pharmacol Exp Ther; 1993 Nov; 267(2):590-5. PubMed ID: 8246132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the potent peptide FK888 with unusual aminoacids: effects on activity on neurokinin receptors.
    Caliendo G; Greco G; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Novellino E
    Farmaco; 1996 Mar; 51(3):197-201. PubMed ID: 8688142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of ibodutant at NK(2) receptor in human colon.
    Santicioli P; Meini S; Giuliani S; Catalani C; Bechi P; Riccadonna S; Ringressi MN; Maggi CA
    Eur J Pharmacol; 2013 Feb; 702(1-3):32-7. PubMed ID: 23376417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiophene bioisosteres of spirocyclic σ receptor ligands: relationships between substitution pattern and σ receptor affinity.
    Oberdorf C; Schepmann D; Vela JM; Buschmann H; Holenz J; Wünsch B
    J Med Chem; 2012 Jun; 55(11):5350-60. PubMed ID: 22515405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Martini E; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    J Med Chem; 2007 Mar; 50(6):1409-13. PubMed ID: 17305327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models.
    Lecci A; Carini F; Tramontana M; D'Aranno V; Marinoni E; Crea A; Bueno L; Fioramonti J; Criscuoli M; Giuliani S; Maggi CA
    J Pharmacol Exp Ther; 2001 Oct; 299(1):247-54. PubMed ID: 11561086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).
    Peretto I; Forlani R; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Bigogno C; Misiano P; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Delcanale M; Salcedo C; Fernández AG; Imbimbo BP
    J Med Chem; 2007 Apr; 50(7):1571-83. PubMed ID: 17352462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and receptor binding of new thieno[2,3-d]-pyrimidines as selective ligands of 5-HT(3) receptors.
    Modica MN; Romeo G; Salerno L; Pittalà V; Siracusa MA; Mereghetti I; Cagnotto A; Mennini T; Gáspár R; Gál A; Falkay G; Palkó M; Maksay G; Fülöp F
    Arch Pharm (Weinheim); 2008 Jun; 341(6):333-43. PubMed ID: 18535994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.
    Kitbunnadaj R; Hashimoto T; Poli E; Zuiderveld OP; Menozzi A; Hidaka R; de Esch IJ; Bakker RA; Menge WM; Yamatodani A; Coruzzi G; Timmerman H; Leurs R
    J Med Chem; 2005 Mar; 48(6):2100-7. PubMed ID: 15771452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of otilonium bromide and ibodutant on the internalization of the NK2 receptor in human colon.
    Cipriani G; Santicioli P; Evangelista S; Maggi CA; Riccadonna S; Ringressi MN; Bechi P; Faussone-Pellegrini MS; Vannucchi MG
    Neurogastroenterol Motil; 2011 Jan; 23(1):96-102, e10. PubMed ID: 20879991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational rigidity versus flexibility in a novel peptidic neurokinin A receptor antagonist.
    Pavone V; Lombardi A; Maggi CA; Quartara L; Pedone C
    J Pept Sci; 1995; 1(4):236-40. PubMed ID: 9223001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
    Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
    J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new structural motif for mu-opioid antagonists.
    Van den Eynde I; Laus G; Schiller PW; Kosson P; Chung NN; Lipkowski AW; Tourwé D
    J Med Chem; 2005 May; 48(10):3644-8. PubMed ID: 15887972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion of an aspartic acid moiety into cyclic pseudopeptides: synthesis and biological characterization of potent antagonists for the human Tachykinin NK-2 receptor.
    Fedi V; Altamura M; Balacco G; Canfarini F; Criscuoli M; Giannotti D; Giolitti A; Giuliani S; Guidi A; Harmat NJ; Nannicini R; Pasqui F; Patacchini R; Perrotta E; Tramontana M; Triolo A; Maggi CA
    J Med Chem; 2004 Dec; 47(27):6935-47. PubMed ID: 15615542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.